Nylex (Calcitonin (Salmon))

Calcitonin (Salmon), the active ingredient in Nylex, is a hormone therapy presented as a dosage form for subcutaneous injection use. It regulates calcium metabolism and is employed in the management of bone‑related disorders such as osteoporosis and Paget's disease, particularly in post‑menopausal women and other at‑risk populations. GNH USA supplies Nylex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Nylex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nylex is a calcitonin preparation that acts on the skeletal remodeling pathway to improve bone health.

- Osteoporosis: Reduces the risk of vertebral fractures in post‑menopausal women. - Paget's disease of bone: Helps decrease the rate of bone turnover and relief of bone pain. - Hyper‑hyper   

The